pillbase.ru

Egrifta

Active substance: tesamorelin

tesamorelin

Centralised EU authorisationActive

Marketing holder: Ferrer Internacional S.A.

Verified 2026-10-09 · EMA

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
US 2
  • EGRIFTA SV
    KIT · tesamorelin
    62064-241
    Theratechnologies Inc.
  • EGRIFTA WR
    KIT · tesamorelin
    62064-381
    Theratechnologies Inc.
Import and control

Control by country

  • United Statesprescription only

    Source: openFDA NDC · record 01a1208e-97a7-7088-a0fe-8aa7c719064d,01a1209b-77c9-79ab-b129-59e6b55f07e5;count=2 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
EMEA/H/C/002427
Registration status
Active
Sources
  • product · EMA · EMEA/H/C/002427 · Verified 2026-10-09
  • registration_status · EMA · EMEA/H/C/002427 · Verified 2026-10-09
  • ingredients.0 · EMA · EMEA/H/C/002427 · Verified 2026-10-09